Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

Published:2017-09 Issue:9 Volume:26 Page:1018-1032
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Wang Shirley V.¹²^ORCID,Schneeweiss Sebastian¹²,Berger Marc L.³,Brown Jeffrey⁴,de Vries Frank⁵,Douglas Ian⁶,Gagne Joshua J.¹²^ORCID,Gini Rosa⁷,Klungel Olaf⁸,Mullins C. Daniel⁹,Nguyen Michael D.¹⁰,Rassen Jeremy A.¹¹,Smeeth Liam⁶,Sturkenboom Miriam¹²,

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics; Brigham and Women's Hospital; MA USA

2. Department of Medicine; Harvard Medical School; MA USA

3. Pfizer; NY USA

4. Department of Population Medicine; Harvard Medical School; MA USA

5. Department of Clinical Pharmacy; Maastricht UMC+; The Netherlands

6. London School of Hygiene and Tropical Medicine; England UK

7. Agenzia regionale di sanità della Toscana; Florence Italy

8. Division of Pharmacoepidemiology & Clinical Pharmacology; Utrecht University; Utrecht Netherlands

9. Pharmaceutical Health Services Research Department; University of Maryland School of Pharmacy; MA USA

10. FDA Center for Drug Evaluation and Research; USA

11. Aetion, Inc.; NY USA

12. Erasmus University Medical Center Rotterdam; Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference70 articles.

1. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J Clin Epidemiol,Apr 2005

2. Transforming Evidence Generation to Support Health and Health Care Decisions;Califf;N Engl J Med,2016

3. Mini-Sentinel and regulatory science--big data rendered fit and functional;Psaty;N Engl J Med,2014

4. Launching PCORnet, a national patient-centered clinical research network;Fleurence;J Am Med Inform Assoc,2014

5. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools;Oliveira;Pharmacoepidemiol Drug Saf,2013

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Exposure As a Predictor in Diabetic Retinopathy Risk Prediction Models—A Systematic Review and Meta-Analysis;American Journal of Ophthalmology;2024-12

2. Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code;Pharmacoepidemiology and Drug Safety;2024-09

3. Examining the Impact of the Current Reimbursement Regulation on Patient Access to Innovative Medical Devices in Taiwan: Insights From 8 Years’ Reimbursement Data;Value in Health Regional Issues;2024-07

4. OpenSAFELY: A platform for analysing electronic health records designed for reproducible research;Pharmacoepidemiology and Drug Safety;2024-05-23

5. Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment;Pharmacoepidemiology and Drug Safety;2024-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3